nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Cisplatin—esophageal cancer	0.275	0.445	CbGbCtD
Sildenafil—ABCC10—Methotrexate—esophageal cancer	0.178	0.289	CbGbCtD
Sildenafil—ABCC4—Methotrexate—esophageal cancer	0.0857	0.139	CbGbCtD
Sildenafil—CYP2C9—Capecitabine—esophageal cancer	0.0524	0.0848	CbGbCtD
Sildenafil—CYP2C9—Cisplatin—esophageal cancer	0.0264	0.0427	CbGbCtD
Sildenafil—PDE6G—lung—esophageal cancer	0.00184	0.0929	CbGeAlD
Sildenafil—PDE6G—lymph node—esophageal cancer	0.00126	0.0636	CbGeAlD
Sildenafil—PDE5A—epithelium—esophageal cancer	0.00115	0.0578	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—esophageal cancer	0.0011	0.0557	CbGeAlD
Sildenafil—ABCC5—bronchus—esophageal cancer	0.00103	0.0521	CbGeAlD
Sildenafil—PDE5A—digestive system—esophageal cancer	0.000871	0.044	CbGeAlD
Sildenafil—ABCC10—bronchus—esophageal cancer	0.000862	0.0435	CbGeAlD
Sildenafil—ABCC10—trachea—esophageal cancer	0.000774	0.0391	CbGeAlD
Sildenafil—PDE5A—lung—esophageal cancer	0.000728	0.0367	CbGeAlD
Sildenafil—ABCC4—bronchus—esophageal cancer	0.000715	0.0361	CbGeAlD
Sildenafil—ABCC10—digestive system—esophageal cancer	0.000666	0.0336	CbGeAlD
Sildenafil—ABCC5—lung—esophageal cancer	0.000665	0.0336	CbGeAlD
Sildenafil—ABCC10—lung—esophageal cancer	0.000556	0.0281	CbGeAlD
Sildenafil—ABCC4—digestive system—esophageal cancer	0.000552	0.0279	CbGeAlD
Sildenafil—PDE5A—lymph node—esophageal cancer	0.000498	0.0251	CbGeAlD
Sildenafil—CYP1A1—epithelium—esophageal cancer	0.000487	0.0246	CbGeAlD
Sildenafil—CYP1A1—bronchus—esophageal cancer	0.000479	0.0242	CbGeAlD
Sildenafil—ABCC4—lung—esophageal cancer	0.000461	0.0233	CbGeAlD
Sildenafil—CYP2C19—digestive system—esophageal cancer	0.000459	0.0232	CbGeAlD
Sildenafil—ABCC5—lymph node—esophageal cancer	0.000455	0.023	CbGeAlD
Sildenafil—Liver function test abnormal—Capecitabine—esophageal cancer	0.000439	0.00259	CcSEcCtD
Sildenafil—Connective tissue disorder—Cisplatin—esophageal cancer	0.000439	0.00259	CcSEcCtD
Sildenafil—Urethral disorder—Cisplatin—esophageal cancer	0.000437	0.00258	CcSEcCtD
Sildenafil—Gynaecomastia—Methotrexate—esophageal cancer	0.000436	0.00258	CcSEcCtD
Sildenafil—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000434	0.00257	CcSEcCtD
Sildenafil—Abdominal pain upper—Capecitabine—esophageal cancer	0.000434	0.00257	CcSEcCtD
Sildenafil—Hypokalaemia—Capecitabine—esophageal cancer	0.000433	0.00256	CcSEcCtD
Sildenafil—CYP1A1—trachea—esophageal cancer	0.00043	0.0217	CbGeAlD
Sildenafil—Visual impairment—Cisplatin—esophageal cancer	0.00043	0.00254	CcSEcCtD
Sildenafil—Breast disorder—Capecitabine—esophageal cancer	0.00043	0.00254	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000428	0.00253	CcSEcCtD
Sildenafil—Nasopharyngitis—Capecitabine—esophageal cancer	0.000425	0.00251	CcSEcCtD
Sildenafil—Gastritis—Capecitabine—esophageal cancer	0.000421	0.00249	CcSEcCtD
Sildenafil—Muscular weakness—Capecitabine—esophageal cancer	0.000419	0.00248	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000419	0.00248	CcSEcCtD
Sildenafil—Eye disorder—Cisplatin—esophageal cancer	0.000417	0.00246	CcSEcCtD
Sildenafil—Tinnitus—Cisplatin—esophageal cancer	0.000416	0.00246	CcSEcCtD
Sildenafil—Cardiac disorder—Cisplatin—esophageal cancer	0.000414	0.00245	CcSEcCtD
Sildenafil—Flushing—Cisplatin—esophageal cancer	0.000414	0.00245	CcSEcCtD
Sildenafil—Abdominal distension—Capecitabine—esophageal cancer	0.000414	0.00244	CcSEcCtD
Sildenafil—Dysphagia—Capecitabine—esophageal cancer	0.000411	0.00243	CcSEcCtD
Sildenafil—Influenza—Capecitabine—esophageal cancer	0.000411	0.00243	CcSEcCtD
Sildenafil—Asthma—Capecitabine—esophageal cancer	0.000411	0.00243	CcSEcCtD
Sildenafil—Diabetes mellitus—Methotrexate—esophageal cancer	0.000407	0.0024	CcSEcCtD
Sildenafil—Immune system disorder—Cisplatin—esophageal cancer	0.000403	0.00238	CcSEcCtD
Sildenafil—Mediastinal disorder—Cisplatin—esophageal cancer	0.000402	0.00238	CcSEcCtD
Sildenafil—Angina pectoris—Capecitabine—esophageal cancer	0.0004	0.00236	CcSEcCtD
Sildenafil—Arrhythmia—Cisplatin—esophageal cancer	0.000399	0.00235	CcSEcCtD
Sildenafil—Bronchitis—Capecitabine—esophageal cancer	0.000395	0.00233	CcSEcCtD
Sildenafil—Alopecia—Cisplatin—esophageal cancer	0.000394	0.00233	CcSEcCtD
Sildenafil—Malnutrition—Cisplatin—esophageal cancer	0.000388	0.00229	CcSEcCtD
Sildenafil—Erythema—Cisplatin—esophageal cancer	0.000388	0.00229	CcSEcCtD
Sildenafil—Flatulence—Cisplatin—esophageal cancer	0.000383	0.00226	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000382	0.00226	CcSEcCtD
Sildenafil—ABCC10—lymph node—esophageal cancer	0.00038	0.0192	CbGeAlD
Sildenafil—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000375	0.00222	CcSEcCtD
Sildenafil—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000375	0.00222	CcSEcCtD
Sildenafil—Weight increased—Capecitabine—esophageal cancer	0.000374	0.00221	CcSEcCtD
Sildenafil—Visual disturbance—Methotrexate—esophageal cancer	0.000374	0.00221	CcSEcCtD
Sildenafil—Hyperglycaemia—Capecitabine—esophageal cancer	0.000371	0.00219	CcSEcCtD
Sildenafil—CYP1A1—digestive system—esophageal cancer	0.00037	0.0187	CbGeAlD
Sildenafil—Pneumonia—Capecitabine—esophageal cancer	0.000369	0.00218	CcSEcCtD
Sildenafil—Infestation NOS—Capecitabine—esophageal cancer	0.000366	0.00216	CcSEcCtD
Sildenafil—Infestation—Capecitabine—esophageal cancer	0.000366	0.00216	CcSEcCtD
Sildenafil—Vision blurred—Cisplatin—esophageal cancer	0.000366	0.00216	CcSEcCtD
Sildenafil—Depression—Capecitabine—esophageal cancer	0.000365	0.00216	CcSEcCtD
Sildenafil—Tremor—Cisplatin—esophageal cancer	0.000364	0.00215	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000363	0.00215	CcSEcCtD
Sildenafil—CYP3A5—digestive system—esophageal cancer	0.000362	0.0183	CbGeAlD
Sildenafil—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000361	0.00213	CcSEcCtD
Sildenafil—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000361	0.00213	CcSEcCtD
Sildenafil—Ill-defined disorder—Cisplatin—esophageal cancer	0.00036	0.00213	CcSEcCtD
Sildenafil—Renal failure—Capecitabine—esophageal cancer	0.00036	0.00213	CcSEcCtD
Sildenafil—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000359	0.00212	CcSEcCtD
Sildenafil—Myocardial infarction—Capecitabine—esophageal cancer	0.000359	0.00212	CcSEcCtD
Sildenafil—Anaemia—Cisplatin—esophageal cancer	0.000359	0.00212	CcSEcCtD
Sildenafil—Stomatitis—Capecitabine—esophageal cancer	0.000357	0.00211	CcSEcCtD
Sildenafil—CYP2C9—digestive system—esophageal cancer	0.000356	0.018	CbGeAlD
Sildenafil—Urinary tract infection—Capecitabine—esophageal cancer	0.000356	0.0021	CcSEcCtD
Sildenafil—Conjunctivitis—Capecitabine—esophageal cancer	0.000356	0.0021	CcSEcCtD
Sildenafil—Osteoarthritis—Methotrexate—esophageal cancer	0.000354	0.00209	CcSEcCtD
Sildenafil—Malaise—Cisplatin—esophageal cancer	0.00035	0.00207	CcSEcCtD
Sildenafil—Haematuria—Capecitabine—esophageal cancer	0.000349	0.00206	CcSEcCtD
Sildenafil—Leukopenia—Cisplatin—esophageal cancer	0.000348	0.00205	CcSEcCtD
Sildenafil—Epistaxis—Capecitabine—esophageal cancer	0.000346	0.00204	CcSEcCtD
Sildenafil—Irritability—Methotrexate—esophageal cancer	0.000338	0.002	CcSEcCtD
Sildenafil—CYP2E1—digestive system—esophageal cancer	0.000338	0.017	CbGeAlD
Sildenafil—Convulsion—Cisplatin—esophageal cancer	0.000337	0.00199	CcSEcCtD
Sildenafil—Ataxia—Methotrexate—esophageal cancer	0.000333	0.00197	CcSEcCtD
Sildenafil—Myalgia—Cisplatin—esophageal cancer	0.000331	0.00195	CcSEcCtD
Sildenafil—Haemoglobin—Capecitabine—esophageal cancer	0.000331	0.00195	CcSEcCtD
Sildenafil—Rhinitis—Capecitabine—esophageal cancer	0.00033	0.00195	CcSEcCtD
Sildenafil—Anxiety—Cisplatin—esophageal cancer	0.00033	0.00195	CcSEcCtD
Sildenafil—Haemorrhage—Capecitabine—esophageal cancer	0.000329	0.00194	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000328	0.00194	CcSEcCtD
Sildenafil—Hypoaesthesia—Capecitabine—esophageal cancer	0.000327	0.00193	CcSEcCtD
Sildenafil—Liver function test abnormal—Methotrexate—esophageal cancer	0.000327	0.00193	CcSEcCtD
Sildenafil—Discomfort—Cisplatin—esophageal cancer	0.000327	0.00193	CcSEcCtD
Sildenafil—Pharyngitis—Capecitabine—esophageal cancer	0.000326	0.00193	CcSEcCtD
Sildenafil—Urinary tract disorder—Capecitabine—esophageal cancer	0.000325	0.00192	CcSEcCtD
Sildenafil—Oedema peripheral—Capecitabine—esophageal cancer	0.000324	0.00191	CcSEcCtD
Sildenafil—Connective tissue disorder—Capecitabine—esophageal cancer	0.000323	0.00191	CcSEcCtD
Sildenafil—Urethral disorder—Capecitabine—esophageal cancer	0.000322	0.0019	CcSEcCtD
Sildenafil—Breast disorder—Methotrexate—esophageal cancer	0.00032	0.00189	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000319	0.00188	CcSEcCtD
Sildenafil—Oedema—Cisplatin—esophageal cancer	0.000317	0.00187	CcSEcCtD
Sildenafil—Visual impairment—Capecitabine—esophageal cancer	0.000317	0.00187	CcSEcCtD
Sildenafil—ABCC4—lymph node—esophageal cancer	0.000315	0.0159	CbGeAlD
Sildenafil—Infection—Cisplatin—esophageal cancer	0.000315	0.00186	CcSEcCtD
Sildenafil—Erythema multiforme—Capecitabine—esophageal cancer	0.000311	0.00184	CcSEcCtD
Sildenafil—Nervous system disorder—Cisplatin—esophageal cancer	0.000311	0.00184	CcSEcCtD
Sildenafil—Tachycardia—Cisplatin—esophageal cancer	0.000309	0.00183	CcSEcCtD
Sildenafil—CYP1A1—lung—esophageal cancer	0.000309	0.0156	CbGeAlD
Sildenafil—Skin disorder—Cisplatin—esophageal cancer	0.000308	0.00182	CcSEcCtD
Sildenafil—Eye disorder—Capecitabine—esophageal cancer	0.000307	0.00182	CcSEcCtD
Sildenafil—Tinnitus—Capecitabine—esophageal cancer	0.000307	0.00181	CcSEcCtD
Sildenafil—Hyperhidrosis—Cisplatin—esophageal cancer	0.000306	0.00181	CcSEcCtD
Sildenafil—Asthma—Methotrexate—esophageal cancer	0.000306	0.00181	CcSEcCtD
Sildenafil—Flushing—Capecitabine—esophageal cancer	0.000305	0.0018	CcSEcCtD
Sildenafil—Cardiac disorder—Capecitabine—esophageal cancer	0.000305	0.0018	CcSEcCtD
Sildenafil—CYP3A5—lung—esophageal cancer	0.000302	0.0153	CbGeAlD
Sildenafil—Anorexia—Cisplatin—esophageal cancer	0.000302	0.00179	CcSEcCtD
Sildenafil—Angiopathy—Capecitabine—esophageal cancer	0.000298	0.00176	CcSEcCtD
Sildenafil—Immune system disorder—Capecitabine—esophageal cancer	0.000297	0.00176	CcSEcCtD
Sildenafil—Mediastinal disorder—Capecitabine—esophageal cancer	0.000296	0.00175	CcSEcCtD
Sildenafil—Hypotension—Cisplatin—esophageal cancer	0.000296	0.00175	CcSEcCtD
Sildenafil—Chills—Capecitabine—esophageal cancer	0.000295	0.00174	CcSEcCtD
Sildenafil—Arrhythmia—Capecitabine—esophageal cancer	0.000294	0.00174	CcSEcCtD
Sildenafil—Alopecia—Capecitabine—esophageal cancer	0.000291	0.00172	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000289	0.00171	CcSEcCtD
Sildenafil—Mental disorder—Capecitabine—esophageal cancer	0.000288	0.0017	CcSEcCtD
Sildenafil—Erythema—Capecitabine—esophageal cancer	0.000286	0.00169	CcSEcCtD
Sildenafil—Malnutrition—Capecitabine—esophageal cancer	0.000286	0.00169	CcSEcCtD
Sildenafil—Paraesthesia—Cisplatin—esophageal cancer	0.000285	0.00168	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000284	0.00168	CcSEcCtD
Sildenafil—Dyspnoea—Cisplatin—esophageal cancer	0.000283	0.00167	CcSEcCtD
Sildenafil—Flatulence—Capecitabine—esophageal cancer	0.000282	0.00167	CcSEcCtD
Sildenafil—CYP2E1—lung—esophageal cancer	0.000282	0.0142	CbGeAlD
Sildenafil—Erectile dysfunction—Methotrexate—esophageal cancer	0.000282	0.00166	CcSEcCtD
Sildenafil—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000279	0.00165	CcSEcCtD
Sildenafil—Back pain—Capecitabine—esophageal cancer	0.000277	0.00164	CcSEcCtD
Sildenafil—Decreased appetite—Cisplatin—esophageal cancer	0.000276	0.00163	CcSEcCtD
Sildenafil—Pneumonia—Methotrexate—esophageal cancer	0.000274	0.00162	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000274	0.00162	CcSEcCtD
Sildenafil—Infestation—Methotrexate—esophageal cancer	0.000273	0.00161	CcSEcCtD
Sildenafil—Infestation NOS—Methotrexate—esophageal cancer	0.000273	0.00161	CcSEcCtD
Sildenafil—Depression—Methotrexate—esophageal cancer	0.000272	0.00161	CcSEcCtD
Sildenafil—CYP3A4—digestive system—esophageal cancer	0.000272	0.0137	CbGeAlD
Sildenafil—Pain—Cisplatin—esophageal cancer	0.000271	0.0016	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00027	0.0016	CcSEcCtD
Sildenafil—Vision blurred—Capecitabine—esophageal cancer	0.00027	0.00159	CcSEcCtD
Sildenafil—Tremor—Capecitabine—esophageal cancer	0.000268	0.00158	CcSEcCtD
Sildenafil—Renal failure—Methotrexate—esophageal cancer	0.000268	0.00158	CcSEcCtD
Sildenafil—CYP2D6—digestive system—esophageal cancer	0.000267	0.0135	CbGeAlD
Sildenafil—Stomatitis—Methotrexate—esophageal cancer	0.000266	0.00157	CcSEcCtD
Sildenafil—Ill-defined disorder—Capecitabine—esophageal cancer	0.000266	0.00157	CcSEcCtD
Sildenafil—Conjunctivitis—Methotrexate—esophageal cancer	0.000265	0.00157	CcSEcCtD
Sildenafil—Anaemia—Capecitabine—esophageal cancer	0.000265	0.00156	CcSEcCtD
Sildenafil—Sweating—Methotrexate—esophageal cancer	0.000262	0.00154	CcSEcCtD
Sildenafil—Feeling abnormal—Cisplatin—esophageal cancer	0.000261	0.00154	CcSEcCtD
Sildenafil—Haematuria—Methotrexate—esophageal cancer	0.00026	0.00154	CcSEcCtD
Sildenafil—Malaise—Capecitabine—esophageal cancer	0.000258	0.00153	CcSEcCtD
Sildenafil—Epistaxis—Methotrexate—esophageal cancer	0.000257	0.00152	CcSEcCtD
Sildenafil—Vertigo—Capecitabine—esophageal cancer	0.000257	0.00152	CcSEcCtD
Sildenafil—Syncope—Capecitabine—esophageal cancer	0.000257	0.00152	CcSEcCtD
Sildenafil—Leukopenia—Capecitabine—esophageal cancer	0.000256	0.00151	CcSEcCtD
Sildenafil—Palpitations—Capecitabine—esophageal cancer	0.000253	0.00149	CcSEcCtD
Sildenafil—Loss of consciousness—Capecitabine—esophageal cancer	0.000252	0.00149	CcSEcCtD
Sildenafil—Body temperature increased—Cisplatin—esophageal cancer	0.000251	0.00148	CcSEcCtD
Sildenafil—Cough—Capecitabine—esophageal cancer	0.00025	0.00148	CcSEcCtD
Sildenafil—Hypertension—Capecitabine—esophageal cancer	0.000247	0.00146	CcSEcCtD
Sildenafil—Haemoglobin—Methotrexate—esophageal cancer	0.000246	0.00145	CcSEcCtD
Sildenafil—Haemorrhage—Methotrexate—esophageal cancer	0.000245	0.00145	CcSEcCtD
Sildenafil—Arthralgia—Capecitabine—esophageal cancer	0.000244	0.00144	CcSEcCtD
Sildenafil—Chest pain—Capecitabine—esophageal cancer	0.000244	0.00144	CcSEcCtD
Sildenafil—Myalgia—Capecitabine—esophageal cancer	0.000244	0.00144	CcSEcCtD
Sildenafil—Pharyngitis—Methotrexate—esophageal cancer	0.000243	0.00144	CcSEcCtD
Sildenafil—Anxiety—Capecitabine—esophageal cancer	0.000243	0.00144	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000242	0.00143	CcSEcCtD
Sildenafil—Urinary tract disorder—Methotrexate—esophageal cancer	0.000242	0.00143	CcSEcCtD
Sildenafil—Discomfort—Capecitabine—esophageal cancer	0.000241	0.00142	CcSEcCtD
Sildenafil—Urethral disorder—Methotrexate—esophageal cancer	0.00024	0.00142	CcSEcCtD
Sildenafil—Dry mouth—Capecitabine—esophageal cancer	0.000238	0.00141	CcSEcCtD
Sildenafil—Visual impairment—Methotrexate—esophageal cancer	0.000236	0.00139	CcSEcCtD
Sildenafil—Oedema—Capecitabine—esophageal cancer	0.000234	0.00138	CcSEcCtD
Sildenafil—Hypersensitivity—Cisplatin—esophageal cancer	0.000234	0.00138	CcSEcCtD
Sildenafil—Infection—Capecitabine—esophageal cancer	0.000232	0.00137	CcSEcCtD
Sildenafil—Erythema multiforme—Methotrexate—esophageal cancer	0.000232	0.00137	CcSEcCtD
Sildenafil—Shock—Capecitabine—esophageal cancer	0.00023	0.00136	CcSEcCtD
Sildenafil—Nervous system disorder—Capecitabine—esophageal cancer	0.000229	0.00135	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—esophageal cancer	0.000229	0.00135	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—esophageal cancer	0.000228	0.00135	CcSEcCtD
Sildenafil—Tachycardia—Capecitabine—esophageal cancer	0.000228	0.00135	CcSEcCtD
Sildenafil—Asthenia—Cisplatin—esophageal cancer	0.000227	0.00134	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—esophageal cancer	0.000227	0.00134	CcSEcCtD
Sildenafil—Skin disorder—Capecitabine—esophageal cancer	0.000227	0.00134	CcSEcCtD
Sildenafil—Hyperhidrosis—Capecitabine—esophageal cancer	0.000226	0.00133	CcSEcCtD
Sildenafil—Anorexia—Capecitabine—esophageal cancer	0.000223	0.00132	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—esophageal cancer	0.000222	0.00131	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—esophageal cancer	0.000221	0.00131	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—esophageal cancer	0.000221	0.0013	CcSEcCtD
Sildenafil—Chills—Methotrexate—esophageal cancer	0.00022	0.0013	CcSEcCtD
Sildenafil—Hypotension—Capecitabine—esophageal cancer	0.000218	0.00129	CcSEcCtD
Sildenafil—Diarrhoea—Cisplatin—esophageal cancer	0.000217	0.00128	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—esophageal cancer	0.000216	0.00128	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—esophageal cancer	0.000215	0.00127	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—esophageal cancer	0.000213	0.00126	CcSEcCtD
Sildenafil—Erythema—Methotrexate—esophageal cancer	0.000213	0.00126	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000213	0.00126	CcSEcCtD
Sildenafil—CYP1A1—lymph node—esophageal cancer	0.000211	0.0107	CbGeAlD
Sildenafil—Insomnia—Capecitabine—esophageal cancer	0.000211	0.00125	CcSEcCtD
Sildenafil—Paraesthesia—Capecitabine—esophageal cancer	0.00021	0.00124	CcSEcCtD
Sildenafil—Dyspnoea—Capecitabine—esophageal cancer	0.000208	0.00123	CcSEcCtD
Sildenafil—Back pain—Methotrexate—esophageal cancer	0.000206	0.00122	CcSEcCtD
Sildenafil—Dyspepsia—Capecitabine—esophageal cancer	0.000206	0.00122	CcSEcCtD
Sildenafil—Decreased appetite—Capecitabine—esophageal cancer	0.000203	0.0012	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000202	0.00119	CcSEcCtD
Sildenafil—Vomiting—Cisplatin—esophageal cancer	0.000202	0.00119	CcSEcCtD
Sildenafil—Fatigue—Capecitabine—esophageal cancer	0.000201	0.00119	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—esophageal cancer	0.000201	0.00119	CcSEcCtD
Sildenafil—Rash—Cisplatin—esophageal cancer	0.0002	0.00118	CcSEcCtD
Sildenafil—Constipation—Capecitabine—esophageal cancer	0.0002	0.00118	CcSEcCtD
Sildenafil—Pain—Capecitabine—esophageal cancer	0.0002	0.00118	CcSEcCtD
Sildenafil—Dermatitis—Cisplatin—esophageal cancer	0.0002	0.00118	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—esophageal cancer	0.000198	0.00117	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—esophageal cancer	0.000197	0.00116	CcSEcCtD
Sildenafil—Feeling abnormal—Capecitabine—esophageal cancer	0.000193	0.00114	CcSEcCtD
Sildenafil—Malaise—Methotrexate—esophageal cancer	0.000192	0.00114	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—esophageal cancer	0.000192	0.00113	CcSEcCtD
Sildenafil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000191	0.00113	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—esophageal cancer	0.000191	0.00113	CcSEcCtD
Sildenafil—Nausea—Cisplatin—esophageal cancer	0.000188	0.00111	CcSEcCtD
Sildenafil—Cough—Methotrexate—esophageal cancer	0.000186	0.0011	CcSEcCtD
Sildenafil—Urticaria—Capecitabine—esophageal cancer	0.000186	0.0011	CcSEcCtD
Sildenafil—Abdominal pain—Capecitabine—esophageal cancer	0.000185	0.00109	CcSEcCtD
Sildenafil—Body temperature increased—Capecitabine—esophageal cancer	0.000185	0.00109	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—esophageal cancer	0.000185	0.00109	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—esophageal cancer	0.000181	0.00107	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—esophageal cancer	0.000181	0.00107	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—esophageal cancer	0.000181	0.00107	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00018	0.00106	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—esophageal cancer	0.000179	0.00106	CcSEcCtD
Sildenafil—Infection—Methotrexate—esophageal cancer	0.000173	0.00102	CcSEcCtD
Sildenafil—Hypersensitivity—Capecitabine—esophageal cancer	0.000172	0.00102	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—esophageal cancer	0.000171	0.00101	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—esophageal cancer	0.000169	0.000998	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—esophageal cancer	0.000168	0.000994	CcSEcCtD
Sildenafil—Asthenia—Capecitabine—esophageal cancer	0.000168	0.00099	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—esophageal cancer	0.000166	0.00098	CcSEcCtD
Sildenafil—Pruritus—Capecitabine—esophageal cancer	0.000165	0.000977	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—esophageal cancer	0.000163	0.00096	CcSEcCtD
Sildenafil—Diarrhoea—Capecitabine—esophageal cancer	0.00016	0.000945	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000159	0.000936	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—esophageal cancer	0.000157	0.00093	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—esophageal cancer	0.000156	0.000923	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—esophageal cancer	0.000155	0.000916	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—esophageal cancer	0.000155	0.000914	CcSEcCtD
Sildenafil—Dizziness—Capecitabine—esophageal cancer	0.000155	0.000913	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—esophageal cancer	0.000153	0.000905	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—esophageal cancer	0.000151	0.000893	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00015	0.000887	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—esophageal cancer	0.00015	0.000886	CcSEcCtD
Sildenafil—Pain—Methotrexate—esophageal cancer	0.000149	0.000879	CcSEcCtD
Sildenafil—Vomiting—Capecitabine—esophageal cancer	0.000149	0.000878	CcSEcCtD
Sildenafil—Rash—Capecitabine—esophageal cancer	0.000147	0.00087	CcSEcCtD
Sildenafil—Dermatitis—Capecitabine—esophageal cancer	0.000147	0.00087	CcSEcCtD
Sildenafil—Headache—Capecitabine—esophageal cancer	0.000146	0.000865	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—esophageal cancer	0.000143	0.000847	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000142	0.00084	CcSEcCtD
Sildenafil—Nausea—Capecitabine—esophageal cancer	0.000139	0.00082	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—esophageal cancer	0.000138	0.000816	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—esophageal cancer	0.000138	0.000812	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—esophageal cancer	0.000138	0.000812	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—esophageal cancer	0.000128	0.000757	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—esophageal cancer	0.000125	0.000737	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—esophageal cancer	0.000123	0.000727	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—esophageal cancer	0.000119	0.000703	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—esophageal cancer	0.000115	0.00068	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—esophageal cancer	0.000111	0.000653	CcSEcCtD
Sildenafil—Rash—Methotrexate—esophageal cancer	0.00011	0.000648	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—esophageal cancer	0.00011	0.000647	CcSEcCtD
Sildenafil—Headache—Methotrexate—esophageal cancer	0.000109	0.000644	CcSEcCtD
Sildenafil—Nausea—Methotrexate—esophageal cancer	0.000103	0.00061	CcSEcCtD
Sildenafil—CYP2D6—Metabolism—CA2—esophageal cancer	2.39e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.39e-05	0.000124	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ENO1—esophageal cancer	2.38e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS1—esophageal cancer	2.38e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TPI1—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTO1—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CA2—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTO1—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TPI1—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NOS3—esophageal cancer	2.36e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PSME2—esophageal cancer	2.35e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PSME1—esophageal cancer	2.35e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALOX15—esophageal cancer	2.35e-05	0.000122	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EP300—esophageal cancer	2.33e-05	0.000121	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.32e-05	0.00012	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFBR2—esophageal cancer	2.31e-05	0.00012	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALDOB—esophageal cancer	2.28e-05	0.000118	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALDOB—esophageal cancer	2.27e-05	0.000118	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TPI1—esophageal cancer	2.24e-05	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTO1—esophageal cancer	2.24e-05	0.000116	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.22e-05	0.000115	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADH7—esophageal cancer	2.22e-05	0.000115	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CREBBP—esophageal cancer	2.21e-05	0.000115	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB2—esophageal cancer	2.21e-05	0.000115	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.2e-05	0.000114	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADH7—esophageal cancer	2.2e-05	0.000114	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.19e-05	0.000113	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SMAD4—esophageal cancer	2.19e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.19e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.18e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.17e-05	0.000112	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.17e-05	0.000112	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—esophageal cancer	2.16e-05	0.000112	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALDOB—esophageal cancer	2.15e-05	0.000111	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.12e-05	0.00011	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GAPDH—esophageal cancer	2.07e-05	0.000107	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNG7—esophageal cancer	2.06e-05	0.000107	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNG7—esophageal cancer	2.06e-05	0.000107	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CRABP1—esophageal cancer	2.05e-05	0.000106	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—esophageal cancer	2.03e-05	0.000105	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMP—esophageal cancer	2.02e-05	0.000105	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1B1—esophageal cancer	2.02e-05	0.000105	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.01e-05	0.000104	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.01e-05	0.000104	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—esophageal cancer	1.99e-05	0.000103	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—NOS3—esophageal cancer	1.98e-05	0.000103	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.97e-05	0.000102	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.95e-05	0.000101	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNG7—esophageal cancer	1.95e-05	0.000101	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALDH2—esophageal cancer	1.93e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.93e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.93e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.92e-05	9.94e-05	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—esophageal cancer	1.9e-05	9.87e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.9e-05	9.86e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1A—esophageal cancer	1.89e-05	9.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMP—esophageal cancer	1.86e-05	9.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMP—esophageal cancer	1.85e-05	9.56e-05	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—esophageal cancer	1.84e-05	9.54e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.84e-05	9.53e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.84e-05	9.51e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TPI1—esophageal cancer	1.83e-05	9.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.83e-05	9.49e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALDH2—esophageal cancer	1.82e-05	9.45e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.82e-05	9.42e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.82e-05	9.4e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.81e-05	9.38e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—esophageal cancer	1.81e-05	9.38e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EP300—esophageal cancer	1.8e-05	9.32e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.8e-05	9.3e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HIF1A—esophageal cancer	1.79e-05	9.27e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.77e-05	9.15e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.76e-05	9.09e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.75e-05	9.07e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.74e-05	9e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTT1—esophageal cancer	1.74e-05	8.99e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—esophageal cancer	1.73e-05	8.94e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ENO1—esophageal cancer	1.72e-05	8.93e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.72e-05	8.93e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ENO1—esophageal cancer	1.72e-05	8.91e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.72e-05	8.91e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2A6—esophageal cancer	1.72e-05	8.88e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—esophageal cancer	1.71e-05	8.86e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.71e-05	8.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA1—esophageal cancer	1.71e-05	8.85e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.71e-05	8.85e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSME2—esophageal cancer	1.7e-05	8.8e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSME1—esophageal cancer	1.7e-05	8.8e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSME1—esophageal cancer	1.7e-05	8.78e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSME2—esophageal cancer	1.7e-05	8.78e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.69e-05	8.75e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.68e-05	8.72e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TPI1—esophageal cancer	1.68e-05	8.72e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.67e-05	8.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TPI1—esophageal cancer	1.67e-05	8.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.67e-05	8.65e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—esophageal cancer	1.67e-05	8.64e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.67e-05	8.64e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS1—esophageal cancer	1.63e-05	8.42e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ENO1—esophageal cancer	1.63e-05	8.42e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.61e-05	8.36e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	1.61e-05	8.35e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSME2—esophageal cancer	1.6e-05	8.3e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSME1—esophageal cancer	1.6e-05	8.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.6e-05	8.29e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNG7—esophageal cancer	1.59e-05	8.25e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—esophageal cancer	1.57e-05	8.12e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA2—esophageal cancer	1.56e-05	8.1e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.55e-05	8.05e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.54e-05	7.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.54e-05	7.98e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—esophageal cancer	1.53e-05	7.94e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.53e-05	7.91e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—EP300—esophageal cancer	1.51e-05	7.8e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.49e-05	7.73e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.47e-05	7.6e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNG7—esophageal cancer	1.47e-05	7.59e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.46e-05	7.58e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	1.46e-05	7.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.45e-05	7.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADH7—esophageal cancer	1.45e-05	7.53e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNG7—esophageal cancer	1.45e-05	7.52e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	1.44e-05	7.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.42e-05	7.36e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.4e-05	7.27e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.4e-05	7.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.4e-05	7.24e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.38e-05	7.16e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.38e-05	7.14e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.38e-05	7.13e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.37e-05	7.11e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.37e-05	7.11e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.36e-05	7.05e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ENO1—esophageal cancer	1.33e-05	6.89e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.33e-05	6.89e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—esophageal cancer	1.33e-05	6.89e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSME2—esophageal cancer	1.31e-05	6.79e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSME1—esophageal cancer	1.31e-05	6.79e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	1.31e-05	6.78e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.31e-05	6.76e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.3e-05	6.73e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.29e-05	6.71e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.29e-05	6.69e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.28e-05	6.63e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.26e-05	6.52e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.26e-05	6.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.25e-05	6.46e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	1.22e-05	6.34e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ENO1—esophageal cancer	1.22e-05	6.34e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.22e-05	6.34e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMP—esophageal cancer	1.22e-05	6.31e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ENO1—esophageal cancer	1.21e-05	6.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.21e-05	6.28e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.21e-05	6.26e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSME1—esophageal cancer	1.21e-05	6.25e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSME2—esophageal cancer	1.21e-05	6.25e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.21e-05	6.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSME1—esophageal cancer	1.2e-05	6.19e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSME2—esophageal cancer	1.2e-05	6.19e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—esophageal cancer	1.19e-05	6.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.18e-05	6.14e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.16e-05	6.03e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.15e-05	5.98e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.14e-05	5.93e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—esophageal cancer	1.14e-05	5.9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.13e-05	5.86e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.11e-05	5.77e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—esophageal cancer	1.11e-05	5.77e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.1e-05	5.7e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TPI1—esophageal cancer	1.1e-05	5.7e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	1.08e-05	5.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.06e-05	5.51e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.06e-05	5.47e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	1.05e-05	5.42e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.04e-05	5.41e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.04e-05	5.39e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.03e-05	5.34e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.02e-05	5.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.01e-05	5.22e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NOS3—esophageal cancer	9.98e-06	5.17e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—esophageal cancer	9.96e-06	5.16e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.78e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—esophageal cancer	9.71e-06	5.03e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP19A1—esophageal cancer	9.7e-06	5.02e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNG7—esophageal cancer	9.58e-06	4.96e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.52e-06	4.93e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—esophageal cancer	9.32e-06	4.83e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—esophageal cancer	9.12e-06	4.73e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.98e-06	4.65e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.93e-06	4.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.85e-06	4.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.68e-06	4.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—esophageal cancer	8.68e-06	4.49e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.61e-06	4.46e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.57e-06	4.44e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.54e-06	4.42e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.5e-06	4.4e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	8.49e-06	4.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.44e-06	4.37e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CREBBP—esophageal cancer	8.07e-06	4.18e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CREBBP—esophageal cancer	8.05e-06	4.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO1—esophageal cancer	8e-06	4.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS1—esophageal cancer	8e-06	4.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSME1—esophageal cancer	7.88e-06	4.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSME2—esophageal cancer	7.88e-06	4.08e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CREBBP—esophageal cancer	7.61e-06	3.94e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—esophageal cancer	7.59e-06	3.93e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	7.36e-06	3.81e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NOS3—esophageal cancer	7.23e-06	3.74e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NOS3—esophageal cancer	7.21e-06	3.74e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—esophageal cancer	7.12e-06	3.69e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.04e-06	3.65e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NOS3—esophageal cancer	6.81e-06	3.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.8e-06	3.52e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—esophageal cancer	6.61e-06	3.42e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—esophageal cancer	6.6e-06	3.42e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.42e-06	3.33e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.4e-06	3.31e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—esophageal cancer	6.23e-06	3.23e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.23e-06	3.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.84e-06	3.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.73e-06	2.97e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.68e-06	2.94e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—esophageal cancer	5.61e-06	2.91e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.6e-06	2.9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NOS3—esophageal cancer	5.58e-06	2.89e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—esophageal cancer	5.5e-06	2.85e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—esophageal cancer	5.49e-06	2.84e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—esophageal cancer	5.18e-06	2.68e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NOS3—esophageal cancer	5.13e-06	2.66e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.1e-06	2.64e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NOS3—esophageal cancer	5.08e-06	2.63e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.69e-06	2.43e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.65e-06	2.41e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—esophageal cancer	4.24e-06	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.07e-06	2.11e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.06e-06	2.1e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—esophageal cancer	3.9e-06	2.02e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—esophageal cancer	3.87e-06	2e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—esophageal cancer	3.83e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.74e-06	1.94e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NOS3—esophageal cancer	3.35e-06	1.74e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.14e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.07e-06	1.59e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.89e-06	1.49e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.86e-06	1.48e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—esophageal cancer	2.55e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.89e-06	9.77e-06	CbGpPWpGaD
